New antivirals - mechanism of action and resistance development

被引：42

作者：

Balzarini, J ^{[1
]}

Naesens, L ^{[1
]}

De Clercq, E ^{[1
]}

机构：

[1] Katholieke Univ Leuven, Rega Inst Med Res, B-3000 Louvain, Belgium

来源：

CURRENT OPINION IN MICROBIOLOGY | 1998年 / 1卷 / 05期

关键词：

D O I：

10.1016/S1369-5274(98)80086-6

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

In recent years, several novel treatment modalities emerged for a number of virus infections, including lamivudine for hepatitis B virus, abacavir, adefovir dipivoxyl and apropovir disprometil for human immunodeficiency virus, cidofovir for cytomegalovirus, and famciclovir (the oral prodrug of penciclovir) and cidofovir for other herpesviruses (i.e. herpes simplex virus and varicella-zoster virus). For all drugs, resistance eventually develops upon prolonged administration to the infected individuals, albeit to a varying extent. In addition, new mutations related to multidrug resistance have recently been identified.

引用

页码：535 / 546

页数：12

共 73 条

[1] Hepatitis B virus polymerase mutations during antiviral therapy in a patient following liver transplantation
Aye, TT
Bartholomeusz, A
Shaw, T
Bowden, S
Breschkin, A
McMillan, J
Angus, P
Locarnini, S
[J]. JOURNAL OF HEPATOLOGY, 1997, 26 (05) : 1148 - 1153
[2] Single amino acid changes in the DNA polymerase confer foscarnet resistance and slow-growth phenotype, while mutations in the UL97-encoded phosphotransferase confer ganciclovir resistance in three double-resistant human cytomegalovirus strains recovered from patients with AIDS
Baldanti, F
Underwood, MR
Stanat, SC
Biron, KK
Chou, SW
Sarasini, A
Silini, E
Gerna, G
[J]. JOURNAL OF VIROLOGY, 1996, 70 (03) : 1390 - 1395
[3] Baldanti F, 1998, ANTIMICROB AGENTS CH, V42, P444
[4] MARKED INVIVO ANTIRETROVIRUS ACTIVITY OF 9-(2-PHOSPHONYLMETHOXY-ETHYL)ADENINE, A SELECTIVE ANTI-HUMAN IMMUNODEFICIENCY VIRUS AGENT
BALZARINI, J
NAESENS, L
HERDEWIJN, P
ROSENBERG, I
HOLY, A
PAUWELS, R
BABA, M
JOHNS, DG
DECLERCQ, E
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (01) : 332 - 336
[5] INTRACELLULAR METABOLISM AND MECHANISM OF ANTIRETROVIRUS ACTION OF 9-(2-PHOSPHONYLMETHOXYETHYL)ADENINE, A POTENT ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS COMPOUND
BALZARINI, J
ZHANG, H
HERDEWIJN, P
JOHNS, DG
DECLERCQ, E
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (04) : 1499 - 1503
[6] DIFFERENTIAL ANTIHERPESVIRUS AND ANTIRETROVIRUS EFFECTS OF THE (S) AND (R) ENANTIOMERS OF ACYCLIC NUCLEOSIDE PHOSPHONATES - POTENT AND SELECTIVE INVITRO AND INVIVO ANTIRETROVIRUS ACTIVITIES OF (R)-9-(2-PHOSPHONOMETHOXYPROPYL)-2,6-DIAMINOPURINE
BALZARINI, J
HOLY, A
JINDRICH, J
NAESENS, L
SNOECK, R
SCHOLS, D
DECLERCQ, E
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (02) : 332 - 338
[7] BALZARINI J, IN PRESS BIOCH PHARM
[8] Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation
Bartholomew, MM
Jansen, RW
Jeffers, LJ
Reddy, KR
Johnson, LC
Bunzendahl, H
Condreay, LD
Tzakis, AG
Schiff, ER
Brown, NA
[J]. LANCET, 1997, 349 (9044) : 20 - 22
[9] EFFICACY OF LAMIVUDINE ON REPLICATION OF HEPATITIS-B VIRUS IN HIV-INFECTED PATIENTS
BENHAMOU, Y
DOHIN, E
LUNELFABIANI, F
POYNARD, T
HURAUX, JM
KATLAMA, C
OPOLON, P
GENTILINI, M
[J]. LANCET, 1995, 345 (8946): : 396 - 397
[10] Bowen EF, 1997, J VIROL METHODS, V68, P225

← 1 2 3 4 5 6 7 8 →